The expression level of the MCM9 protein is correlated to the cisplatin resistance of some prostate cancer cell lines (Fig. 6f,g) and a cancer-derived mutation of MCM8 inactivated MCM8 (Fig. 7a). Here, MCM8 is linked to prostate carcinoma.